Jefferies Downgrades Cerevel Therapeutics (CERE) to Hold

Jefferies analyst Michael J. Yee downgraded Cerevel Therapeutics (NASDAQ: CERE) from Buy to Hold with a price target of $45.00 (from $40.00).

For an analyst ratings summary and ratings history on Cerevel Therapeutics click here. For more ratings news on Cerevel Therapeutics click here.

Shares of Cerevel Therapeutics closed at $41.39 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
• Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities